Moreover, dynamic transcriptional alterations of TAMs in the irradiated and recurrent tumors have been observed in mouse and human GBM, and CSF-1R inhibition could overcome resistance of pre-clinical models to radiotherapy (95). Here, CSF1R is linked to glioblastoma.